Generis Farmacêutica
Generis Farmacêutica is a private Portuguese pharmaceutical manufacturer, founded in 2006 and headquartered in Amadora, Portugal. With 251-500 employees, it is described as the largest pharmaceutical company in Portugal, producing medicines for domestic pharmacy, hospital, and wholesale distribution channels.
- Company typePrivate
- Founded2006
- HeadquartersAmadora, Portugal
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Generis Farmacêutica does
Generis Farmacêutica is a private Portuguese pharmaceutical manufacturer headquartered in Amadora, Portugal. Founded in 2006, the company is described as the largest pharmaceutical company domiciled in Portugal, operating with a workforce of 251-500 employees. Its core business is pharmaceutical manufacturing, operating within the regulated European pharmaceutical market under EMA and Portuguese Infarmed oversight.
The company manufactures and supplies pharmaceutical products for the Portuguese market, and by virtue of its position as the country's largest domestic producer, likely serves national pharmacy chains, hospital procurement channels, and pharmaceutical wholesalers. As a manufacturer in a heavily regulated industry, Generis's product portfolio would consist of medicines holding regulatory marketing authorizations, with manufacturing subject to GMP standards. The 19-year operating history and mid-large employee base indicate a meaningful, mature production footprint. The "Generis" name is commonly associated with generic medicines in the European pharma context, though the source material does not explicitly confirm a generics-only focus.
The business model is that of a B2B pharmaceutical manufacturer, generating revenue from the sale of manufactured pharmaceutical products through distribution channels to pharmacies, hospitals, and wholesalers. Revenue mechanics, pricing strategy, product mix, and specific customer relationships are not disclosed in the available source material. No funding rounds, M&A activity, partnerships, product launches, or technology stack details are available in the inputs, limiting further granularity on growth drivers and strategic positioning.
Generis Farmacêutica firmographics
Firmographics- Name
- Generis Farmacêutica
- Website
- https://generis.pt
- Company type
- Private
- Founded year
- 2006
- Headcount range
- 251–500 employees
- Short description
- Generis Farmacêutica is a private Portuguese pharmaceutical manufacturer, founded in 2006 and headquartered in Amadora, Portugal. With 251-500 employees, it is described as the largest pharmaceutical company in Portugal, producing medicines for domestic pharmacy, hospital, and wholesale distribution channels.
- Ownership category
- akta.pro rank
Generis Farmacêutica industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)
Keywords
Where Generis Farmacêutica is headquartered
LocationHeadquarters
- HQ city
- Amadora
- HQ country
- Portugal
- HQ region
- Europe
Markets served
Generis Farmacêutica business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Generis Farmacêutica product offering
Product offeringCore offering
Generis Farmacêutica is a pharmaceutical manufacturer producing generic drug formulations. Founded in 2006 and headquartered in Amadora, Portugal, the company is the largest Portuguese pharmaceutical company, manufacturing medicines for distribution through healthcare supply channels.
Differentiator
Problem solved
Functional benefit
Companies that use Generis Farmacêutica
Customer profileIdeal customer profiles1 record
Generis Farmacêutica technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Generis Farmacêutica partnerships and signals
Strategic signalRecent moves1 record
Generis Farmacêutica competitors and assessment
Company assessmentBroad incumbents
- Sandoz: Sandoz is Novartis's generics and biosimilars division and one of the largest European generics manufacturers. It competes directly with Generis in the off-patent medicines space and represents the type of scaled competitor Generis must differentiate against in tenders and supply contracts.
- Viatris: Viatris (formed from Mylan and Upjohn) is a global generics and specialty pharma company with significant European presence. It competes with Generis across multiple therapeutic categories and is representative of the larger, more diversified players Generis faces in European tenders.
- Teva Pharmaceutical Industries: Teva is the world's largest generics manufacturer, offering a broad portfolio of off-patent medicines across all major therapeutic areas. It is comparable to Generis as a competitor in the same European generics market, though at vastly greater scale and with global reach.
Direct peers
- KRKA: KRKA is a Slovenian-based generics manufacturer with a strong presence in Central and Eastern European markets. Like Generis, it operates from a smaller EU country as a base for broader European expansion, making its business model and competitive dynamics highly comparable.
- Stada Arzneimittel: Stada is a leading European generics manufacturer with a portfolio strategy and geographic focus (Germany, Eastern Europe) comparable to Generis' domestic-and-European positioning. It represents a directly comparable mid-sized European generics business model.
- Accord Healthcare: Accord Healthcare is the generics arm of Intas Pharmaceuticals with a strong European footprint across retail generics, hospital injectables, and biosimilars. It is directly comparable to Generis as a competitor in the EU off-patent medicines market.
- Zentiva: Zentiva is a European-focused generics manufacturer headquartered in Prague, serving patients across the EU. Its domestic-market leadership combined with pan-European distribution mirrors Generis' positioning as the largest Portuguese pharma seeking broader EU reach.
Emerging players
- Aurobindo Pharma: Aurobindo is an India-based generics manufacturer with growing European operations through its subsidiary Apotex Europe. It represents the type of cost-competitive Asian generics player increasingly active in the European market alongside Generis.
Regional players
- Laboratórios Basi: Basi is another Portuguese pharmaceutical manufacturer specializing in injectables and sterile products. While smaller and more focused on specific dosage forms, it competes with Generis in the same Portuguese market and faces similar domestic-versus-export dynamics.
- Laboratorios Normon: Normon is a Spanish generics manufacturer with a comparable Iberian Peninsula focus and similar positioning as a domestic leader with selective European export activity. It faces Generis in cross-border Iberian distribution and southern EU tenders.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks4 records
Key highlights5 records
Customer concentration
Generis Farmacêutica social profiles
Digital presenceGeneris Farmacêutica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Generis Farmacêutica leadership team
Management profileNumber of profiles
Profiles1 record
Generis Farmacêutica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Generis Farmacêutica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Generis Farmacêutica
What does Generis Farmacêutica do?
Generis Farmacêutica is a pharmaceutical manufacturer producing generic drug formulations. Founded in 2006 and headquartered in Amadora, Portugal, the company is the largest Portuguese pharmaceutical company, manufacturing medicines for distribution through healthcare supply channels.
Is Generis Farmacêutica a public or private company?
Generis Farmacêutica is a private company. It is classified as unknown.
When was Generis Farmacêutica founded?
Generis Farmacêutica was founded in 2006. It employs 251 to 500 people.
Where is Generis Farmacêutica based?
Generis Farmacêutica is headquartered in Amadora, Portugal, in the Europe region.
Who are Generis Farmacêutica's main competitors?
Broad incumbents on record are Sandoz, Viatris and Teva Pharmaceutical Industries. Direct peers are KRKA, Stada Arzneimittel, Accord Healthcare and Zentiva. Aurobindo Pharma is listed as an emerging player. Regional players are Laboratórios Basi and Laboratorios Normon.
Does Generis Farmacêutica have an API?
No public API is recorded for Generis Farmacêutica.
What industry is Generis Farmacêutica in?
Generis Farmacêutica's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO). Its NAICS code is 325412 and its SIC code is 2834.